In a report released today, Thorsten Strauss from Norddeutsche Landesbank maintained a Hold rating on Qiagen (QGEN). The company’s shares closed last Wednesday at $51.70, close to its 52-week high of $55.27.
According to TipRanks.com, Strauss ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.8% and a 50.0% success rate. Strauss covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, LANXESS, and Linde.
The word on The Street in general, suggests a Hold analyst consensus rating for Qiagen with a $56.90 average price target.
See today’s analyst top recommended stocks >>
Based on Qiagen’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $484 million and net profit of $16.91 million. In comparison, last year the company earned revenue of $383 million and had a GAAP net loss of $161 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.